Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations
Jeremy Hobart(Peninsula College of Medicine and Dentistry), Alan J. Thompson(Queen Mary University of London), Stefan Cano(Health Economics and Outcomes Research (United Kingdom)), John Zajicek(Peninsula College of Medicine and Dentistry)
Cited by 497
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k